Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer—a review
Author:
Publisher
Informa UK Limited
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
http://www.tandfonline.com/doi/pdf/10.3109/10799893.2010.488649
Reference66 articles.
1. Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2. Why is cancer drug discovery so difficult?
3. The challenge of cancer control in Africa
4. Paul Ehrlich's magic bullet concept: 100 years of progress
5. Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex;Chemistry & Biodiversity;2023-07-13
2. TR35 Exerts Anti-tumor Effects by Modulating Mitogen-Activated Protein Kinase and STAT3 Signaling in Lung Cancer Cells;Frontiers in Cell and Developmental Biology;2021-10-25
3. An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-09
4. Angel or Devil ? - CDK8 as the new drug target;European Journal of Medicinal Chemistry;2021-03
5. ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation;Cancers;2021-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3